Amundi Asset Management US’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$136K Buy
+700
New +$144K ﹤0.01% 1480
2020
Q4
Sell
-61
Closed -$9K 1568
2020
Q3
$9K Hold
61
﹤0.01% 1530
2020
Q2
$8K Buy
+61
New +$7.18K ﹤0.01% 1559
2019
Q4
Sell
-22,700
Closed -$1.74M 1657
2019
Q3
$1.74M Sell
22,700
-24,200
-52% -$2.12M ﹤0.01% 1145
2019
Q2
$4.03M Sell
46,900
-2,600
-5% -$177K ﹤0.01% 1003
2019
Q1
$2.92M Buy
+49,500
New +$2.85M ﹤0.01% 1027

Other funds holding RGEN

Amundi Asset Management US's RGEN Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in Repligen (RGEN) in Q1 2021: 700 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #1480 among its holdings. This is a return to the name: Amundi Asset Management US previously reported a position in RGEN as recently as Q3 2020.

Amundi Asset Management US first reported a position in RGEN in Q1 2019 and has held it in 6 quarters since. The position peaked at $4.03M in Q2 2019. 459 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.

  • Amundi Asset Management US held 700 shares of Repligen worth $136K as of Q1 2021.
  • Repligen was a new Amundi Asset Management US position in Q1 2021.
  • Repligen made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1480 holding.
  • Amundi Asset Management US first reported a position in Repligen in Q1 2019 and has held it in 6 quarters since.
  • Amundi Asset Management US's Repligen position peaked at $4.03M in Q2 2019.
  • 459 funds tracked by Wall St. Rank held Repligen as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.